News ArchivesRead News
Memory Program for Parkinson's Helps Mood, Too
Friday October 04, 2013
MedPage Today - An individualized neurocognitive intervention was more helpful for memory and mood than general supportive care for patients with Parkinson's disease and mild cognitive impairment, a researcher said here.
For instance, on the letter-number sequencing test, patients randomized to the neurocognitive intervention performed significantly better, with results having an effect size of 0.57 (f=4.01, P=0.046), according to Sarah K. Lageman, PhD, of Virginia Commonwealth University in Richmond.
In addition, 6 months after the intervention, scores on the multidimensional anxiety questionnaire were significantly improved, showing an effect size of 0.61 (f=9.42, P=0.022), she reported in a poster session at the World Parkinson Congress here.
"This intervention is intended to help patients maintain memory function and coping ability, and to provide them with a structured approach to deal with their problems as they come up," Lageman told MedPage Today.
The neurodegenerative process of Parkinson's disease progressively compromises patients' ability to be active and independent, but neurocognitive interventions specifically targeted to these patients have been lacking.
To fill that gap, she and her colleagues developed a 2-month, once-weekly program incorporating practical techniques for memory enhancement and problem solving, and are conducting a randomized trial comparing the intervention with a conventional, nondirective supportive therapy.
Thus far, eight patients and four controls have completed the program, and an additional 17 have been enrolled.
All participants had mild cognitive impairment as determined by scores one to two standard deviations below the mean on at least two mental function domains. Their mean age was 64, two-thirds were men, and almost all were white. The mean educational attainment was 17 years.
The first three sessions focused on education about Parkinson's-related changes in cognition and the introduction of a memory book and calendar as practical tools to help compensate for memory difficulties.
Sessions four through six reviewed the use of the memory book and calendar, identifying problem areas and troubleshooting techniques, and introduced problem-solving steps.
The last two sessions expanded the use of the calendar, identifying barriers to habitual use and developing strategies to facilitate daily use.
The nondirective support group involved client-centered psychotherapy with active listening and discussion, but without any training in specific memory or problem-solving skills.
Among the significantly superior outcomes for the neurocognitive program were:
California verbal learning test T-score, effect size 0.61 (f = 9.23, P=0.023)
Auditory attention at 6 months, effect size 0.92 (f = 72, P<0.001)
Nonspecific effects of therapy, effect size 0.26 (f = 4.46, P=0.22)
Trends also were seen for Parkinson's-related quality of life on the domains of stigma and social functioning, on clinician-rated motor symptoms, and on the California verbal learning test long-delay free recall test.
"Even with the small numbers thus far, we have been able to see improvements on learning and working memory in these cognitively impaired individuals. If a neurocognitive program can help keep people functioning better at least for a couple of years, that's a benefit," Lageman commented.
The study was funded by the Michael J. Fox Foundation. Lageman reported no disclosures.
Walsh, N. (4 Oct 2013). MedPage Today. Memory Program for Parkinson's Helps Mood, Too. www.medpagetoday.com.
Recent NewsOct 18 - Brain disconnections may contribute to Parkinson's hallucinations
Oct 18 - Fighting Parkinson's disease through dance
Oct 17 - Scientists Identify Structure of PINK1, Key Parkinson’s-protective Protein
Oct 17 - Diabetes drug cuts Parkinson's risk by 28 percent, study finds
Oct 10 - Advances in Brain Pacemaker Reduces Tremors, Helps Parkinson's Sufferers Live a More Normal Life
Oct 10 - Medical History Could Help Predict Parkinson's Disease Risk Long Before Diagnosis
Oct 3 - Changes in Olfactory Bulb Explain Loss of Smell in Early Stages of Parkinson’s Disease, Study Finds
Oct 3 - Sleep Disturbances May Worsen Motor Symptoms in Parkinson’s Disease, Study Suggests
Sep 12 - Australian Researchers Develop New Diagnostic Tool to Spot Early Signs of Parkinson’s
Sep 11 - GeneFo Webinar to Focus on Using Humor to Manage Parkinson’s Disease
Sep 6 - Parkinson’s and the ‘D’ word
Sep 6 - Compounds in Asthma Drugs Might Be Used as Parkinson’s Treatment
Sep 5 - AstraZeneca Joins Takeda, Berg to Advance Development of Parkinson’s Disease Therapies
Sep 1 - Stem Cell Transplant Trial in Parkinson’s Patients Planned After Test in Japan Succeeds in Monkeys
Sep 1 - Titan to Start Phase 1/2 Study of Subdermal Implant to Deliver Requip to Parkinson’s Patients
Aug 30 - FDA Refuses Acorda’s Inbrija New Drug Application Due to Manufacturing Questions
Aug 23 - Support Groups: Are They for You?
Aug 22 - Internet Visits with Parkinson’s Specialist Can Be as Effective as In-person Visits, Trial Finds
Aug 21 - Cavion’s New CMO to Lead Cav3 Platform Development for Neurological Diseases
Aug 15 - Singing Helps Early-stage Parkinson’s Patients Retain Speech, Respiratory Control, Studies Show